FIGURE 1
Incidence rates* for male lung,…
FIGURE 1
Incidence rates* for male lung, bronchial, and tracheal cancers, by state/area and U.S.…
FIGURE 1Incidence rates* for male lung, bronchial, and tracheal cancers, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 males, age adjusted to the 2000 U.S. standard population. † West: 53.5; Midwest: 78.6; Northeast: 72.0; South: 80.8. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 2
Incidence rates* for female lung,…
FIGURE 2
Incidence rates* for female lung, bronchial, and tracheal cancers, by state/area and U.S.…
FIGURE 2Incidence rates* for female lung, bronchial, and tracheal cancers, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population. † West: 42.7; Midwest: 57.4; Northeast: 56.0; South: 53.8. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 3
Incidence rates* for male laryngeal…
FIGURE 3
Incidence rates* for male laryngeal cancer, by state/area and U.S. census region †…
FIGURE 3Incidence rates* for male laryngeal cancer, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 males, age adjusted to the 2000 U.S. standard population. † West: 4.0; Midwest: 6.4; Northeast: 6.1; South: 6.8. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 4
Incidence rates* for female laryngeal…
FIGURE 4
Incidence rates* for female laryngeal cancer, by state/ area and U.S. census region…
FIGURE 4Incidence rates* for female laryngeal cancer, by state/ area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population. † West: 0.8; Midwest: 1.6; Northeast: 1.4; South: 1.5. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 5
Incidence rates* for male oral…
FIGURE 5
Incidence rates* for male oral cavity and pharyngeal cancers, by state/area and U.S.…
FIGURE 5Incidence rates* for male oral cavity and pharyngeal cancers, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 males, age adjusted to the 2000 U.S. standard population. † West: 15.5; Midwest: 17.7; Northeast: 16.6; South: 18.6. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 6
Incidence rates* for female oral…
FIGURE 6
Incidence rates* for female oral cavity and pharyngeal cancers, by state/area and U.S.…
FIGURE 6Incidence rates* for female oral cavity and pharyngeal cancers, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population. † West: 5.9; Midwest: 6.5; Northeast: 6.5; South: 6.5. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 7
Incidence rates* for male esophageal…
FIGURE 7
Incidence rates* for male esophageal cancer, by state/ area and U.S. census region…
FIGURE 7Incidence rates* for male esophageal cancer, by state/ area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 males, age adjusted to the 2000 U.S. standard population. † West: 6.9; Midwest: 8.9; Northeast: 8.6; South: 7.7. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 8
Incidence rates* for female esophageal…
FIGURE 8
Incidence rates* for female esophageal cancer, by state/ area and U.S. census region…
FIGURE 8Incidence rates* for female esophageal cancer, by state/ area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population. † West: 1.6; Midwest: 1.9; Northeast: 2.0; South: 1.7. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 9
Incidence rates* for male stomach…
FIGURE 9
Incidence rates* for male stomach cancer, by state/area and U.S. census region †…
FIGURE 9Incidence rates* for male stomach cancer, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 males, age adjusted to the 2000 U.S. standard population. † West: 9.1; Midwest: 8.7; Northeast: 10.7; South: 8.7. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 10
Incidence rates* for female stomach…
FIGURE 10
Incidence rates* for female stomach cancer, by state/area and U.S. census region †…
FIGURE 10Incidence rates* for female stomach cancer, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population. † West: 4.8; Midwest: 4.0; Northeast: 5.2; South: 4.6 (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 11
Incidence rates* for male colon…
FIGURE 11
Incidence rates* for male colon and rectal cancers, by state/area and U.S. census…
FIGURE 11Incidence rates* for male colon and rectal cancers, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 males, age adjusted to the 2000 U.S. standard population. † West: 41.4; Midwest: 48.0; Northeast: 46.7; South: 46.6. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 12
Incidence rates* for female colon…
FIGURE 12
Incidence rates* for female colon and rectal cancers, by state/area and U.S. census…
FIGURE 12Incidence rates* for female colon and rectal cancers, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population. † West: 32.0; Midwest: 36.4; Northeast: 36.0; South: 34.7. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 13
Incidence rates* for male liver…
FIGURE 13
Incidence rates* for male liver cancer, by state/area and U.S. census region †…
FIGURE 13Incidence rates* for male liver cancer, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 males, age adjusted to the 2000 U.S. standard population. † West: 12.2; Midwest: 8.8; Northeast: 11.2; South: 11.5. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 14
Incidence rates* for female liver…
FIGURE 14
Incidence rates* for female liver cancer, by state/area and U.S. census region †…
FIGURE 14Incidence rates* for female liver cancer, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population. † West: 4.0; Midwest: 2.8; Northeast: 3.0; South: 3.3. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 15
Incidence rates* for male pancreatic…
FIGURE 15
Incidence rates* for male pancreatic cancer, by state/ area and U.S. census region…
FIGURE 15Incidence rates* for male pancreatic cancer, by state/ area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 males, age adjusted to the 2000 U.S. standard population. † West: 13.2; Midwest: 14.4; Northeast: 15.4; South: 14.1. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 16
Incidence rates* for female pancreatic…
FIGURE 16
Incidence rates* for female pancreatic cancer, by state/ area and U.S. census region…
FIGURE 16Incidence rates* for female pancreatic cancer, by state/ area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population. † West: 10.4; Midwest: 11.1; Northeast: 12.0; South: 10.9. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 17
Incidence rates* for male kidney…
FIGURE 17
Incidence rates* for male kidney and renal pelvis cancers, by state/area and U.S.…
FIGURE 17Incidence rates* for male kidney and renal pelvis cancers, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 males, age adjusted to the 2000 U.S. standard population. † West: 19.7; Midwest: 22.9; Northeast: 22.3; South: 22.2. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 18
Incidence rates* for female kidney…
FIGURE 18
Incidence rates* for female kidney and renal pelvis cancers, by state/area and U.S.…
FIGURE 18Incidence rates* for female kidney and renal pelvis cancers, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population. † West: 9.9; Midwest: 12.1; Northeast: 10.9; South: 11.8. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 19
Incidence rates* for male urinary…
FIGURE 19
Incidence rates* for male urinary bladder cancer, by state/area and U.S. census region…
FIGURE 19Incidence rates* for male urinary bladder cancer, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 males, age adjusted to the 2000 U.S. standard population. † West: 32.5; Midwest: 37.9; Northeast: 42.5; South: 33.0. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 20
Incidence rates* for female urinary…
FIGURE 20
Incidence rates* for female urinary bladder cancer, by state/area and U.S. census region…
FIGURE 20Incidence rates* for female urinary bladder cancer, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population. † West: 7.8; Midwest: 9.4; Northeast: 11.0; South: 8.0. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 21
Incidence rates* for cervical cancer,…
FIGURE 21
Incidence rates* for cervical cancer, by state/area and U.S. census region † —…
FIGURE 21Incidence rates* for cervical cancer, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population. † West: 6.9; Midwest: 7.1; Northeast: 7.1; South: 8.3. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 22
Incidence rates* for male acute…
FIGURE 22
Incidence rates* for male acute myeloid leukemia, by state/area and U.S. census region…
FIGURE 22Incidence rates* for male acute myeloid leukemia, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 males, age adjusted to the 2000 U.S. standard population. † West: 4.9; Midwest: 5.5; Northeast: 5.5; South: 5.0. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
FIGURE 23
Incidence rates* for female acute…
FIGURE 23
Incidence rates* for female acute myeloid leukemia, by state/area and U.S. census region…
FIGURE 23Incidence rates* for female acute myeloid leukemia, by state/area and U.S. census region† — United States,§ 2010–2014 Abbreviations: DC = District of Columbia; PR = Puerto Rico. * New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population. † West: 3.4; Midwest: 3.7; Northeast: 3.7; South: 3.4. (West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Oregon, New Mexico, Utah, Washington, and Wyoming; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.) § Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.) Data for Puerto Rico are included in state-specific analyses but not in U.S. census region analyses.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3